Promyelocytic leukemia protein (Pml) inactivation and reactivated mitogen-activated protein kinases (MAPK) leads to lethal metastatic tumors from indolent PTEN-null prostate tumors followed by overactivation of sterol responsive element-binding proteins (SREBP) with altered total lipid profiles. Here, PML is linked to metastatic neoplasm.